SARS‐CoV‐2 variants and spike mutations involved in second wave of COVID‐19 pandemic in India - Muttineni - 2022 - Transboundary and Emerging Diseases - Wiley Online Library
IJERPH | Free Full-Text | Diagnostic Value of IgM and IgG Detection in COVID-19 Diagnosis by the Mobile Laboratory B-LiFE: A Massive Testing Strategy in the Piedmont Region
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain - ScienceDirect
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination - ScienceDirect
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization - ScienceDirect
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions | Science Translational Medicine
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice | Science Translational Medicine
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant | Clinical Microbiology Reviews
Predictive profiling of SARS-CoV-2 variants by deep mutational learning | bioRxiv
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail | Nature Microbiology
Guidance for surveillance of SARS-CoV-2 variants
Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals | Scientific Reports
Comparative analysis of SARS‐CoV‐2 Omicron BA.2.12.1 and BA.5.2 variants - Ong - 2023 - Journal of Medical Virology - Wiley Online Library
IJERPH | Free Full-Text | Diagnostic Value of IgM and IgG Detection in COVID-19 Diagnosis by the Mobile Laboratory B-LiFE: A Massive Testing Strategy in the Piedmont Region
Predictive profiling of SARS-CoV-2 variants by deep mutational learning | bioRxiv
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite - ScienceDirect
Predictive profiling of SARS-CoV-2 variants by deep mutational learning | bioRxiv
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity | Science Advances
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants - ScienceDirect
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes | PLOS Pathogens
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection | Science Translational Medicine
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes | PLOS Pathogens
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant - ScienceDirect
Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections - Elkashif - 2021 - Clinical & Translational Immunology - Wiley Online Library
Omicron BA.2 (B.1.1.529.2): High Potential for Becoming the Next Dominant Variant | The Journal of Physical Chemistry Letters
